Capital Analysts LLC’s Sabra Healthcare REIT SBRA Stock Holding History

Capital Analysts LLC’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12K	Sell	607 -177	-23%	-$3.51K	﹤0.01%	1259
2026 Q1	$15K	Sell	784 -159	-17%	-$3.13K	﹤0.01%	1189
2025 Q4	$18K	Sell	943 -2	-0.2%	-$37	﹤0.01%	1132
2025 Q3	$18K	Buy	945 +212	+29%	+$3.96K	﹤0.01%	1098
2025 Q2	$14K	Buy	733 +4	+0.5%	+$71	﹤0.01%	1090
2025 Q1	$13K	Buy	729 +456	+167%	+$7.69K	﹤0.01%	1085
2024 Q4	$5K	Hold	273	–	–	﹤0.01%	1158
2024 Q3	$5K	Buy	+273	New	+$4.6K	﹤0.01%	1130
2022 Q1	–	Sell	-250	Closed	-$3K	–	1021
2021 Q4	$3K	Hold	250	–	–	﹤0.01%	940
2021 Q3	$4K	Buy	+250	New	+$4.22K	﹤0.01%	884

Other funds holding SBRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capital Analysts LLC's SBRA Position: Q2 2026 in Review

Capital Analysts LLC reduced its Sabra Healthcare REIT (SBRA) stake by 23% in Q2 2026, selling an estimated $3.51K and leaving 607 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1259.

Capital Analysts LLC first reported a position in SBRA in Q3 2021 and has held it in 10 quarters since. The position peaked at $18K in Q4 2025. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

Capital Analysts LLC held 607 shares of Sabra Healthcare REIT worth $12K as of Q2 2026.
Capital Analysts LLC sold 177 Sabra Healthcare REIT shares in Q2 2026, an estimated $3.51K.
Sabra Healthcare REIT made up ﹤0.01% of Capital Analysts LLC's portfolio in Q2 2026, its #1259 holding.
Capital Analysts LLC first reported a position in Sabra Healthcare REIT in Q3 2021 and has held it in 10 quarters since.
Capital Analysts LLC's Sabra Healthcare REIT position peaked at $18K in Q4 2025.
464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.